A comparison of forward and inverse treatment planning for intensity-modulated radiotherapy of head and neck cancer

By Bar W.   Schwarz M.   Alber M.   Bos L.J.   Mijnheer B.J.   Rasch C.   Schneider C.   Nusslin F.   Damen E.M.F.  

Radiotherapy and Oncology, Vol. 69, Iss. 3, 2003-12 ,pp. : 251-258

Elsevier

Access to resources Recommend Favorite

Phase II Study of Weekly High-dose Cisplatin for Six Cycles in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

By Planting A.S.T.   de Mulder P.H.M.   de Graeff A.   Verweij J.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 61-65

Elsevier

Access to resources Recommend Favorite

Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin

By Gómez-Millán Jaime  

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 321-326

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck

By Fujii Masato   Tsukuda Mamoru   Satake Bunsuke   Kubota Akira   Kida Akinori   Kohno Naoyuki   Okami Kenji   Inuyama Yukio  

International Journal of Clinical Oncology, Vol. 9, Iss. 2, 2004-04 ,pp. : 107-112

Springer Publishing Company

Access to resources Recommend Favorite

Cisplatin and Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer

By Marcu Loredana   van Doorn Tim   Olver Ian  

Acta Oncologica, Vol. 42, Iss. 4, 2003-01 ,pp. : 315-325

Informa Healthcare

Access to resources Recommend Favorite